Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04787289
Status:
RECRUITING
Last Update Posted:
2023-07-27
First Post:
2021-03-01
Brief Title:
A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Sponsor:
British Columbia Cancer Agency
Organization:
British Columbia Cancer Agency
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-01
First Submit QC Date:
March 5 2021
Study First Post Date:
2021-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-06
Last Update Post Date:
2023-07-27
Last Update Post Date Type:
ACTUAL